MTB reporter: Standardized reporting of tumoroid drug screening to guide Molecular Tumor Board treament decisions

• Forschungsstelle: INNOSUISSE
• Projektnummer: 121.649 IP-LS
• Projekttitel Englisch: MTB reporter: Standardized reporting of tumoroid drug screening to guide Molecular Tumor Board treament decisions

Schlüsselwörter (Englisch)

Life sciences, Personalised medicine

Abstract (Englisch)

The aging population creates a costly medical burden. Cancer is a complex disease and requires personalized treatments, as single agents often fail. Using a patient?s cells, we can test treatment efficacy, reducing exposure to toxic, expensive, and inefficient therapies, benefiting society overall.